Disparities in Electronic Patient Portal Use in Prenatal Care: Retrospective Cohort Study.


Journal

Journal of medical Internet research
ISSN: 1438-8871
Titre abrégé: J Med Internet Res
Pays: Canada
ID NLM: 100959882

Informations de publication

Date de publication:
23 09 2019
Historique:
received: 18 04 2019
accepted: 23 07 2019
revised: 23 07 2019
entrez: 6 10 2019
pubmed: 6 10 2019
medline: 21 5 2020
Statut: epublish

Résumé

Electronic patient portals are websites that provide individuals access to their personal health records and allow them to engage through a secure Web-based platform. These portals are becoming increasingly popular in contemporary health care systems. Patient portal use has been found to be beneficial in multiple specialties, especially in the management of chronic disease. However, disparities have been identified in portal use in which racial and ethnic minorities and individuals with lower socioeconomic status have been shown to be less likely to enroll and use patient portals than non-Hispanic white persons and individuals with higher socioeconomic status. Electronic patient portal use by childbearing women has not been well studied, and data on portal use during pregnancy are limited. This study aimed to quantify the use of an electronic patient portal during pregnancy and examine whether disparities related to patients' demographics or clinical characteristics exist. This was a retrospective cohort study of women who received prenatal care at an academic medical center from 2014 to 2016. Clinical records were reviewed for portal use and patient data. Patients were considered enrolled in the portal if they had an account at the time of delivery, and enrollees were compared with nonenrollees. Enrollees were further categorized based on the number of secure messages sent during pregnancy as active (≥1) or inactive (0) users. Bivariable chi-square and multivariable Poisson regression models were used to calculate the incidence rate ratio of portal enrollment and, if enrolled, of active use based on patients' characteristics. Of the 3450 women eligible for inclusion, 2530 (73.33%) enrolled in the portal. Of these enrollees, 72.09% (1824/2530) were active users. There was no difference in portal enrollment by maternal race and ethnicity on multivariable models. Women with public insurance (adjusted incidence rate ratio; aIRR 0.60, 95% CI 0.49-0.84), late enrollment in prenatal care (aIRR 0.78, 95% CI 0.69-0.89 for second trimester and aIRR 0.50, 95% CI 0.39-0.64 for third trimester), and high-risk pregnancies (aIRR 0.82, 95% CI 0.75-0.89) were significantly less likely to enroll. Conversely, nulliparity (aIRR 1.10, 95% CI 1.02-1.20) and having more than 8 prescription medications at prenatal care initiation (aIRR 1.19, 95% CI 1.06-1.32) were associated with greater likelihood of enrollment. Among portal enrollees, the only factor significantly associated with active portal use (ie, secure messaging) was nulliparity (aIRR 1.11, 95% CI 1.01-1.23). Among an obstetric population, multiple clinical and socioeconomic factors were associated with electronic portal enrollment, but not subsequent active use. As portals become more integrated as tools to promote health, efforts should be made to ensure that already vulnerable populations are not further disadvantaged with regard to electronic-based care.

Sections du résumé

BACKGROUND
Electronic patient portals are websites that provide individuals access to their personal health records and allow them to engage through a secure Web-based platform. These portals are becoming increasingly popular in contemporary health care systems. Patient portal use has been found to be beneficial in multiple specialties, especially in the management of chronic disease. However, disparities have been identified in portal use in which racial and ethnic minorities and individuals with lower socioeconomic status have been shown to be less likely to enroll and use patient portals than non-Hispanic white persons and individuals with higher socioeconomic status. Electronic patient portal use by childbearing women has not been well studied, and data on portal use during pregnancy are limited.
OBJECTIVE
This study aimed to quantify the use of an electronic patient portal during pregnancy and examine whether disparities related to patients' demographics or clinical characteristics exist.
METHODS
This was a retrospective cohort study of women who received prenatal care at an academic medical center from 2014 to 2016. Clinical records were reviewed for portal use and patient data. Patients were considered enrolled in the portal if they had an account at the time of delivery, and enrollees were compared with nonenrollees. Enrollees were further categorized based on the number of secure messages sent during pregnancy as active (≥1) or inactive (0) users. Bivariable chi-square and multivariable Poisson regression models were used to calculate the incidence rate ratio of portal enrollment and, if enrolled, of active use based on patients' characteristics.
RESULTS
Of the 3450 women eligible for inclusion, 2530 (73.33%) enrolled in the portal. Of these enrollees, 72.09% (1824/2530) were active users. There was no difference in portal enrollment by maternal race and ethnicity on multivariable models. Women with public insurance (adjusted incidence rate ratio; aIRR 0.60, 95% CI 0.49-0.84), late enrollment in prenatal care (aIRR 0.78, 95% CI 0.69-0.89 for second trimester and aIRR 0.50, 95% CI 0.39-0.64 for third trimester), and high-risk pregnancies (aIRR 0.82, 95% CI 0.75-0.89) were significantly less likely to enroll. Conversely, nulliparity (aIRR 1.10, 95% CI 1.02-1.20) and having more than 8 prescription medications at prenatal care initiation (aIRR 1.19, 95% CI 1.06-1.32) were associated with greater likelihood of enrollment. Among portal enrollees, the only factor significantly associated with active portal use (ie, secure messaging) was nulliparity (aIRR 1.11, 95% CI 1.01-1.23).
CONCLUSIONS
Among an obstetric population, multiple clinical and socioeconomic factors were associated with electronic portal enrollment, but not subsequent active use. As portals become more integrated as tools to promote health, efforts should be made to ensure that already vulnerable populations are not further disadvantaged with regard to electronic-based care.

Identifiants

pubmed: 31586367
pii: v21i9e14445
doi: 10.2196/14445
pmc: PMC6818527
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

e14445

Subventions

Organisme : NICHD NIH HHS
ID : K12 HD050121
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR001422
Pays : United States

Informations de copyright

©Erinma P Ukoha, Joe Feinglass, Lynn M Yee. Originally published in the Journal of Medical Internet Research (http://www.jmir.org), 23.09.2019.

Références

Appl Clin Inform. 2017 Jul 05;8(3):698-709
pubmed: 28678891
J Med Internet Res. 2016 Jul 01;18(7):e179
pubmed: 27369696
AMIA Annu Symp Proc. 2006;:871
pubmed: 17238491
J Med Internet Res. 2015 Jun 23;17(6):e148
pubmed: 26104044
J Am Med Inform Assoc. 2009 Sep-Oct;16(5):683-9
pubmed: 19567790
Diabetes Care. 2009 Jul;32(7):1182-7
pubmed: 19366959
J Gen Intern Med. 2011 Oct;26(10):1112-6
pubmed: 21538166
J Am Board Fam Med. 2016 Sep-Oct;29(5):592-603
pubmed: 27613792
J Am Med Inform Assoc. 2017 Apr 1;24(e1):e173-e177
pubmed: 27413120
J Am Med Inform Assoc. 2011 Dec;18 Suppl 1:i8-12
pubmed: 22071530
Curr Diab Rep. 2010 Dec;10(6):422-35
pubmed: 20890688
J Am Med Inform Assoc. 2006 Jan-Feb;13(1):91-5
pubmed: 16221943
J Gen Intern Med. 2013 Jul;28(7):914-20
pubmed: 23423453
J Med Internet Res. 2012 Nov 26;14(6):e162
pubmed: 23183044
Diabetes Care. 2013 Sep;36(9):2726-33
pubmed: 23628618
J Med Internet Res. 2017 Oct 17;19(10):e345
pubmed: 29042345
Am Fam Physician. 2015 Sep 1;92(5):391-7
pubmed: 26371574
Am J Epidemiol. 2004 Apr 1;159(7):702-6
pubmed: 15033648
Ann Intern Med. 2013 Nov 19;159(10):677-87
pubmed: 24247673
Diabetes Technol Ther. 2016 Sep;18(9):555-60
pubmed: 27398824
J Med Internet Res. 2015 Feb 10;17(2):e44
pubmed: 25669240
J Healthc Inf Manag. 2007 Summer;21(3):44-8
pubmed: 19195293
J Am Med Inform Assoc. 2013 May 1;20(3):519-25
pubmed: 23242764
Perspect Health Inf Manag. 2012;9:1-13
pubmed: 23209454
J Midwifery Womens Health. 2018 May;63(3):335-339
pubmed: 29758124
JAMA. 1998 Nov 18;280(19):1690-1
pubmed: 9832001
Telemed J E Health. 2016 Sep;22(9):769-77
pubmed: 27027337
J Obstet Gynaecol Can. 2008 Jan;30(1):38-43
pubmed: 18198066
J Med Internet Res. 2016 Oct 03;18(10):e263
pubmed: 27697748
Health Serv Res. 2014 Feb;49(1 Pt 2):325-46
pubmed: 24359554
J Gen Intern Med. 2011 Oct;26(10):1117-23
pubmed: 21647748

Auteurs

Erinma P Ukoha (EP)

Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California San Francisco, San Francisco, CA, United States.

Joe Feinglass (J)

Division of General Internal Medicine and Geriatrics, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, United States.

Lynn M Yee (LM)

Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, Northwestern University Feinberg School of Medicine, Chicago, IL, United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH